CX Institutional’s Sanofi SNY Stock Holding History

CX Institutional’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7K	Buy	168 +68	+68%	+$2.96K	﹤0.01%	1409
2026 Q2	$4K	Hold	100	–	–	﹤0.01%	1399
2026 Q1	$5K	Sell	100 -149	-60%	-$6.95K	﹤0.01%	1369
2025 Q4	$12K	Buy	249 +218	+703%	+$10.8K	﹤0.01%	1173
2025 Q3	$1K	Hold	31	–	–	﹤0.01%	1363
2025 Q2	$1K	Hold	31	–	–	﹤0.01%	1202
2025 Q1	$2K	Buy	+31	New	+$1.68K	﹤0.01%	1151
2022 Q3	–	Sell	-58	Closed	-$3K	–	1031
2022 Q2	$3K	Buy	+58	New	+$3.08K	﹤0.01%	1073
2018 Q3	–	Sell	-136	Closed	-$5K	–	354
2018 Q2	$5K	Buy	+136	New	+$5.35K	﹤0.01%	270

Other funds holding SNY

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Foundation Resource Management Little Rock, Arkansas $939M AUM 37.7% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

FBT

First Bank & Trust Brookings, South Dakota $687M AUM 18.35% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

CX Institutional's SNY Position: Q3 2026 in Review

CX Institutional increased its Sanofi (SNY) stake by 68% in Q3 2026, buying an estimated $2.96K and bringing the position to 168 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

CX Institutional first reported a position in SNY in Q2 2018 and has held it in 9 quarters since. The position peaked at $12K in Q4 2025. 151 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

CX Institutional held 168 shares of Sanofi worth $7K as of Q3 2026.
CX Institutional bought 68 Sanofi shares in Q3 2026, an estimated $2.96K.
Sanofi made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1409 holding.
CX Institutional first reported a position in Sanofi in Q2 2018 and has held it in 9 quarters since.
CX Institutional's Sanofi position peaked at $12K in Q4 2025.
151 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.